Keros Therapeutics, Inc. — insider transactions
1 transactions on record · KROS · CIK 1664710
Aggregates
computed from the filings belowPurchases, 12m
1
count of open-market buys
Sales, 12m
0
count of open-market sales
Buy / sell ratio, 12m
—
no sales recorded
Distinct insiders, 12m
1
Bought, 3m
$10.6K
Sold, 3m
$0
Median disclosure lag
2.0 d
trade date to filing date
Largest single trade, 24m
$10.6K
2026-07-15
Director share, 12m
100.0%
of transactions where role is stated
Current run
1 buys
consecutive same-direction transactions
Net 3m flow
$10.6K
purchases minus sales
Total on record
1
Transactions
1 most recent shown| Disclosed | Traded | Lag, d | Insider | Role | Transaction | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-17 | 2026-07-15 | 2 | BIENAIME JEAN JACQUES | Director | Open market purchase | 1,000 | $10.61 | $10.6K | filing |